FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions; Delivering 2023 Traceability By Leveraging Blockchain and Digital Recalls Across a Supply Network
Retrieved on:
Tuesday, May 14, 2019
Combining insights from these leading companies with TraceLink's digital supply network will garner compelling information that will contribute to the innovation, security, and interoperability of the U.S. supply chain," said Shabbir Dahod, President and CEO, TraceLink.
Key Points:
- Combining insights from these leading companies with TraceLink's digital supply network will garner compelling information that will contribute to the innovation, security, and interoperability of the U.S. supply chain," said Shabbir Dahod, President and CEO, TraceLink.
- TraceLink's digital recalls worksteam is intended to evaluate and enhance current recall verification and notification processes within the pharmaceutical supply chain by leveraging both lot level and serialization data on a digital supply chain network.
- While individual companies have standing recalls processes in place, the existing recalls process is costly and ineffective when viewed across the supply network.
- TraceLink is the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes.